Want to join the conversation?
$DG 2Q15 Q&A: LaBarr of Stifel asked to discuss the Apparel category a little bit. Is the mid-single digit growth rate the range expected. John answered that Apparels is a key driver of profitability and even through back half of the year going into 2016, teams have got great products lined up, great values for consumer.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.